Sumitomo Dainippon’s 9-Month Profit Sinks 33.5% on US Promotions, Other Factors

Sumitomo Dainippon Pharma suffered a 33.5% plunge on its operating profit in April-December. The company stepped up its promotional activities for three new US launches, resulting in increased costs, which came on top of a pullback from a one-time gain...read more